Adult Clinical Trials: GYNECOLOGICAL
A Randomized Phase III Study of Standard vs. IMRP Pelvic Radiation for Post-Operative Treatment of Endometrial and Cervical Cancer (TIME-C).
To determine if IMRT reduces acute gastrointestinal toxicity in the 5th week (after 23-25 fractions) of pelvic radiation as measured with EPIC.
- Hysterectomy required, bilateral salpingo-oophorectomy at surgeon's discretion
- Chest CT, MRI or PET-CT 90 days prior to registration
- Positive or close margins (<3mm) are ineligible
Arm I: IMRT pelvic radiation treatment
Arm II: 4-field pelvic radiation treatment